Psoriasis Cure Now, a nonprofit patient advocacy group, today reported that biotech and pharmaceutical companies are investigating a record 70 potential new treatments for psoriasis and psoriatic arthritis. The data, culled from published reports and clinical trial recruitment Web sites, shows continued, strong business interest in the psoriasis market. A New York Times article last week called into question the profitability of the psoriasis sector, lighting up psoriasis message boards with concerns that the psoriasis drug pipeline could dry up. The full (and free) report of psoriasis treatments under clinical development is available on the Psoriasis Cure Now Web site: www.psoriasis-cure-now.org/hope.php.
70 Potential New Psoriasis Treatments Being Investigated
February 2, 2007
Most Popular in Physiology
- 6377Best Practices in the Treatment of Hyperpigmentation
- 1286The Body Electric
- 1173Long-term Research Links Dairy and High-Sugar Foods to Acne
- 954What Makes Asian Skin Different?
- 918Dry vs. Dehydrated Skin: Causes and Treatments
- 912Glycation and the Skin
- 911A Good Night’s Sleep Can Put Years on Your Face
- 656Jagger Addresses Rosacea Awareness
- 656Stem Cells and Growth Factors: What You Should Know
- 604The Fitzpatrick Skin Type Classification Scale
- Preventing PIH When Treating Skin of Color
11/20/2015, Jennifer Novoseletsky
- What Makes Asian Skin Different?
9/28/2015, Jennifer Novoseletsky
- The Science Behind Skin at Face & Body Midwest
3/13/2016, Jennifer Novoseletsky
- Researchers Unlock Skin's "Virome" Secrets
11/17/2015, Jennifer Novoseletsky
- New Variants Identified for Eczema Genetics
10/23/2015, Jennifer Novoseletsky